UNSPSC 51352002: Gestodene

This classification denotes a therapeutic progestin with the molecular formula C21H26O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1664P6E6MI, chemically known as 18,19-dinorpregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)- but generally known as gestodene, which bears US NIH Compound Identifier 43249. European Medicines Agency schedules Gestodene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07901MIG.

UNSPSC 51352002 Gestodene is a Commodity code representing a specific progestin pharmaceutical ingredient used in oral contraceptive formulations. State and local governments procure gestodene-containing birth control products primarily through public health departments, Medicaid programs, family planning clinics, and correctional health services to support preventive reproductive health care for eligible populations. The ingredient appears in branded and generic oral contraceptive tablets dispensed by state and county health agencies, typically as part of standardized formularies or negotiated pharmaceutical contracts.

The source contains no recent state or local contract opportunities tagged to this code, making it difficult to characterize current issuing-body patterns, geographic concentration, or representative solicitations. Gestodene procurement at the state and local level is generally embedded within broader pharmaceutical supply agreements or Medicaid managed-care pharmacy networks rather than solicited as standalone line items, which may explain the absence of publicly posted RFP or IFB activity at the Commodity code level.